PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vanadyl diascorbate | 945-749-2 | - | - | - | - | - | 1 | - | - | - | - | Details |
| Vanadium, oxosulfato-, pentahydrate | 635-023-0 | 12439-96-2 | - | - | - | - | 1 | - | - | - | - | Details |
| Vanadium, oxalate complexes | 308-876-9 | 98903-75-4 | - | - | 1 | - | 1 | - | - | - | - | Details |
| Vanadium trichloride oxide | 231-780-2 | 7727-18-6 | - | - | - | - | 1 | - | - | - | - | Details |
| Vanadium trichloride | 231-744-6 | 7718-98-1 | - | - | - | - | 1 | - | - | - | - | Details |
| Vanadium tetrachloride | 231-561-1 | 7632-51-1 | - | - | - | - | 1 | - | - | - | - | Details |
| Vanadium oxysulphate | 949-084-9 | - | - | - | - | - | 1 | - | - | - | - | Details |
| Vanadium oxide sulphate | 248-652-7 | 27774-13-6 | - | - | 1 | - | 1 | - | - | - | - | Details |
| Vanadium dioxide | 234-841-1 | 12036-21-4 | - | - | 1 | - | 1 | - | - | - | - | Details |
| Vanadium dichloride | 234-176-7 | 10580-52-6 | - | - | - | - | 1 | - | - | - | - | Details |
| Vanadium carbide nitride | 601-732-9 | 12069-91-9 | - | - | - | - | 1 | - | - | - | - | Details |
| Vanadium carbide | 235-122-5 | 12070-10-9 | - | - | - | - | 1 | - | - | - | - | Details |
| Vanadium | 231-171-1 | 7440-62-2 | - | - | 1 | - | 1 | - | - | - | - | Details |
| Vanadate(1-), oxo[phosphato(3-)-.kappa.O]-, hydrogen, hydrate (2:1) | 618-920-1 | 93280-40-1 | - | - | - | - | 1 | - | - | - | - | Details |
| Vanadate(1-), oxo(phosphato(3-)-kappaO)-, hydrogen, hydrate (2:1) | 424-390-0 | 93280-40-1 | - | - | - | - | 1 | - | - | - | - | Details |
| Valpromide | 219-394-2 | 2430-27-5 | - | - | - | - | 1 | - | - | - | - | Details |
| Valnoctamide | 224-033-7 | 4171-13-5 | - | - | - | - | 1 | - | - | - | - | Details |
| Valeronitrile | 203-781-8 | 110-59-8 | - | - | - | - | 1 | - | - | - | - | Details |
| Valeramide | 210-974-0 | 626-97-1 | - | - | - | - | 1 | - | - | - | - | Details |
| Valeraldehyde | 203-784-4 | 110-62-3 | - | - | 1 | - | - | - | - | - | - | Details |
| Valdipromide | 257-630-6 | 52061-73-1 | - | - | - | - | 1 | - | - | - | - | Details |
| V159456 | 426-780-6 | - | - | - | - | - | 1 | - | - | - | - | Details |
|
UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine
ITC 826 CONCENTRATE
|
422-720-8 | 166242-53-1 | - | - | - | - | 1 | - | - | - | - | Details |
| Ursodeoxycholic acid | 204-879-3 | 128-13-2 | - | - | 1 | - | - | - | - | - | - | Details |
| Uronium hydrogen sulphate | 244-343-6 | 21351-39-3 | - | - | 1 | - | - | - | - | - | - | Details |